Elsevier

Surgery

Volume 118, Issue 3, September 1995, Pages 472-478
Surgery

Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head*

https://doi.org/10.1016/S0039-6060(05)80361-7Get rights and content

Background. Recurrence in the peritoneum occurs in up to 50% of patients after a potentially curativepancreaticoduodenectomy. Previous authors have implicated preoperative fine-needle aspiration (FNA) as a cause of intraperitoneal tumor dissemination, although prior studies of peritoneal cytology findings have largely involved patients with locally advanced disease.

Methods. A consecutive series of patients referred to our institution between 1991 and 1993 with suspected or biopsy-proven adenocarcinoma of the pancreatic head was studied prospectively. All patients fulfilled criteria for resectability as assessed by computed tomography: no metastatic disease, no encasement of the superior mesenteric or hepatic arteries, and a patent superior mesenteric-portal venous confluence. Peritoneal washings were obtained at the time of staging laparoscopy and/or at subsequent laparotomy. Data regarding peritoneal cytology results, previous FNA, preoperative chemoradiation, eventual resection, pattern of disease recurrence, and survival were collected.

Results. A total of 80 peritoneal washings from 60 consecutive patients were prospectively examined. Forty-nine (82%) of 60 patients underwent FNA before peritoneal washings were obtained. A total of four patients (7%) had positive peritoneal cytology findings: three (6%) of 49 who underwent prior FNA and one (9%) of 11 with no prior FNA. Similarly, no differences in eventual peritoneal failure or short-term survival were observed for patients who underwent prior FNA compared with patients who did not. All four patients with positive peritoneal cytology findings had metastatic disease (liver, three; peritoneum, one) at a median of 4.8 months after diagnosis; three of the four died of disease at a median of 8 months.

Conclusions. Positive peritoneal cytology findings are rare in patients with radiologically resectable adenocarcinoma of the pancreas. When found, positive peritoneal washings are an indicator of advanced disease characterized by unresectability, early metastasis, and short survival. Computed tomographic-guided FNA does not appear to increase the risk for positive peritoneal washings and represents a valid approach to the pretreatment diagnosis of patients with suspected pancreatic malignancy.

References (39)

  • Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer

    Cancer

    (1987)
  • GriffinJF et al.

    Patterns of failure after curative resection of pancreatic carcinoma

    Cancer

    (1990)
  • IshihawaO et al.

    Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head

    Ann Surg

    (1988)
  • OzakiH

    Improvement of pancreatic cancer treatment

    Int J Pancreatol

    (1992)
  • OzakiH et al.

    Effectiveness of multimodality treatment for resectable pancreatic cancer

    Int J Pancreatol

    (1990)
  • TepperJ et al.

    Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy

    Cancer

    (1976)
  • CristDW et al.

    Improved hospital morbidity and survival after the Whipple procedure

    Ann Surg

    (1987)
  • MartinFM et al.

    Clinical and pathologic correlations in patients with periampullary tumors

    Arch Surg

    (1990)
  • PellegriniCA et al.

    An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy

    Arch Surg

    (1989)
  • Cited by (91)

    • Minimally Invasive Staging Surgery for Cancer

      2019, Surgical Oncology Clinics of North America
      Citation Excerpt :

      Although rare to be discovered in the absence of macroscopic peritoneal metastasis, SL may also be used to identify microscopic metastatic disease using peritoneal cytology, which is classified as stage IV disease.37,83 Patients with resected tumors and positive peritoneal cytology have worse median survival than patients with negative cytology83–87; however, peritoneal cytology has not gained widespread adoption, and its use in staging PDAC remains undefined. Most pancreas surgeons found no role for peritoneal cytology in the management of pancreas cancer in a recent expert consensus statement.88

    • Pancreas, Biliary Tract and Intra-Abdominal Organs

      2012, Orell & Sterrett's Fine Needle Aspiration Cytology
    • Pancreas, biliary tract and intra-abdominal organs

      2011, Orell and Sterrett's Fine Needle Aspiration Cytology
    • Diagnosis and Management of Peritoneal Carcinomatosis Arising From Adenocarcinoma of the Colon and Rectum

      2008, Seminars in Oncology
      Citation Excerpt :

      Due to the low likelihood of successful complete surgical resection of peritoneal carcinomatosis from high-grade tumors and the poor intraperitoneal penetration of intravenous chemotherapy, the greatest potential benefit for regional therapy lies in the adjuvant therapy of completely resected primary tumors with a high likelihood of local or regional recurrence. The presense of malignant cells on cytologic examination of ascites or peritoneal washings or the presence of transmural invasion after potentially curative resection of pancreatic, gastric, or colonic malignancies is associated with an increase in local or intraperitoneal recurrence rate.30,32,33 Data regarding adjuvant intraperitoneal therapy for high-risk tumors have been mixed.

    • Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma

      2022, Hepato-Pancreato-Biliary Malignancies: Diagnosis and Treatment in the 21st Century
    View all citing articles on Scopus
    *

    Presented at the Twenty-eighth Annual Meeting of the Pancreas Club,May 15, 1994, New Orleans, La.

    a

    Recipient of an American Cancer Society Clinical Oncology Fellowship Award (94-210-1).

    View full text